Diabetes Care
Blood sugar fell in adults with type 1 diabetes and excess weight
A measure of longer-term blood sugar fell 0.4 to 0.6 percentage points with acmopatide versus 0.3 points with placebo over 16 weeks.A measure of longer-term blood sugar fell 0.4 to 0.6 percentage points with acmopatide versus 0.3 points with placebo over 16 weeks.
Randomized trial · 111 peopleType 1 diabetes
Who was studied111 adults with type 1 diabetes and excess weight, 16 weeks, against placebo
What changedAverage blood sugar fell 0.4 to 0.6 percentage points with acmopatide versus 0.3 points with placebo
The catchThe 16-week trial cannot address lasting benefits or uncommon risks
